Nox2-containing NADPH oxidase and Akt activation play a key role in angiotensin II-induced cardiomyocyte hypertrophy.

Angiotensin II (ANG II) has profound effects on the development and progression of pathological cardiac hypertrophy; however, the intracellular signaling mechanisms are not fully understood. In this study, we used genetic tools to test the hypothesis that increased formation of superoxide (O2-*) radicals from a Rac1-regulated Nox2-containing NADPH oxidase is a key upstream mediator of ANG II-induced activation of serine-threonine kinase Akt, and that this signaling cascade plays a crucial role in ANG II-dependent cardiomyocyte hypertrophy. ANG II caused a significant time-dependent increase in Rac1 activation and O2-* production in primary neonatal rat cardiomyocytes, and these responses were abolished by adenoviral (Ad)-mediated expression of a dominant-negative Rac1 (AdN17Rac1) or cytoplasmic Cu/ZnSOD (AdCu/ZnSOD). Moreover, both AdN17Rac1 and AdCu/ZnSOD significantly attenuated ANG II-stimulated increases in cardiomyocyte size. Quantitative real-time PCR analysis demonstrated that Nox2 is the homolog expressed at highest levels in primary neonatal cardiomyocytes, and small interference RNA (siRNA) directed against it selectively decreased Nox2 expression by >95% and abolished both ANG II-induced O2-* generation and cardiomyocyte hypertrophy. Finally, ANG II caused a time-dependent increase in Akt activity via activation of AT(1) receptors, and this response was abolished by Ad-mediated expression of cytosolic human O2-* dismutase (AdCu/ZnSOD). Furthermore, pretreatment of cardiomyocytes with dominant-negative Akt (AdDNAkt) abolished ANG II-induced cellular hypertrophy. These findings suggest that O2-* generated by a Nox2-containing NADPH oxidase is a central mediator of ANG II-induced Akt activation and cardiomyocyte hypertrophy, and that dysregulation of this signaling cascade may play an important role in cardiac hypertrophy.

[1]  C. Iadecola,et al.  NF-κB Regulates Phagocytic NADPH Oxidase by Inducing the Expression of gp91phox* , 2006, Journal of Biological Chemistry.

[2]  A. Ormsby,et al.  Gene Transfer of NAD(P)H Oxidase Inhibitor to the Vascular Adventitia Attenuates Medial Smooth Muscle Hypertrophy , 2004, Circulation research.

[3]  J. Engelhardt,et al.  Requirement for Rac1-Dependent NADPH Oxidase in the Cardiovascular and Dipsogenic Actions of Angiotensin II in the Brain , 2004, Circulation research.

[4]  R. Chisholm,et al.  Simvastatin modulates angiotensin II signaling pathway by preventing Rac1-mediated upregulation of p27. , 2004, Journal of the American Society of Nephrology : JASN.

[5]  K. Griendling,et al.  Giant atrial septal aneurysm simulating a right atrial tumour , 2004, Heart.

[6]  Masahiro Ito,et al.  Pressure Overload–Induced Myocardial Hypertrophy in Mice Does Not Require gp91phox , 2004, Circulation.

[7]  I. Komuro,et al.  Oxidative stress-induced signal transduction pathways in cardiac myocytes: involvement of ROS in heart diseases. , 2003, Antioxidants & redox signaling.

[8]  E. Olson,et al.  Cardiac hypertrophy: the good, the bad, and the ugly. , 2003, Annual review of physiology.

[9]  C. Croce,et al.  Mechanism of Enhanced Cardiac Function in Mice with Hypertrophy Induced by Overexpressed Akt* , 2003, Journal of Biological Chemistry.

[10]  A. Shah,et al.  Contrasting Roles of NADPH Oxidase Isoforms in Pressure-Overload Versus Angiotensin II–Induced Cardiac Hypertrophy , 2003, Circulation research.

[11]  P. Goldschmidt-Clermont,et al.  Rac regulates cardiovascular superoxide through diverse molecular interactions: more than a binary GTP switch. , 2003, American journal of physiology. Cell physiology.

[12]  MichaelBöhm,et al.  Oxygen Free Radical Release in Human Failing Myocardium Is Associated With Increased Activity of Rac1-GTPase and Represents a Target for Statin Treatment , 2003 .

[13]  H. Abboud,et al.  Nox4 mediates angiotensin II-induced activation of Akt/protein kinase B in mesangial cells. , 2003, American journal of physiology. Renal physiology.

[14]  J. Liao,et al.  NADPH oxidase-derived superoxide anion mediates angiotensin II-induced cardiac hypertrophy. , 2003, Journal of molecular and cellular cardiology.

[15]  R. Weiss,et al.  Genetic redox preconditioning differentially modulates AP-1 and NF kappa B responses following cardiac ischemia/reperfusion injury and protects against necrosis and apoptosis. , 2003, Molecular therapy : the journal of the American Society of Gene Therapy.

[16]  A. Clerk,et al.  Kinases as therapeutic targets for heart failure , 2003, Nature Reviews Drug Discovery.

[17]  D. Spitz,et al.  Superoxide Mediates the Actions of Angiotensin II in the Central Nervous System , 2002, Circulation research.

[18]  C. Croce,et al.  TNF‐α signal transduction in rat neonatal cardiac myocytes: definition of pathways generating from the TNF‐α receptor , 2002 .

[19]  A. Shah,et al.  Activation of NADPH Oxidase During Progression of Cardiac Hypertrophy to Failure , 2002, Hypertension.

[20]  P. Seshiah,et al.  Angiotensin II Stimulation of NAD(P)H Oxidase Activity: Upstream Mediators , 2002, Circulation research.

[21]  A. Shah,et al.  Intracellular Localization and Preassembly of the NADPH Oxidase Complex in Cultured Endothelial Cells* , 2002, The Journal of Biological Chemistry.

[22]  D. Sorescu,et al.  Reactive oxygen species, mitochondria, and NAD(P)H oxidases in the development and progression of heart failure. , 2002, Congestive heart failure.

[23]  P. Kang,et al.  Akt/Protein Kinase B Promotes Organ Growth in Transgenic Mice , 2002, Molecular and Cellular Biology.

[24]  W. R. Taylor,et al.  Superoxide Production and Expression of Nox Family Proteins in Human Atherosclerosis , 2002, Circulation.

[25]  T. Tuschl,et al.  Analysis of gene function in somatic mammalian cells using small interfering RNAs. , 2002, Methods.

[26]  T. Unger.  The role of the renin-angiotensin system in the development of cardiovascular disease. , 2002, The American journal of cardiology.

[27]  A. Shah,et al.  Pivotal Role of a gp91phox-Containing NADPH Oxidase in Angiotensin II-Induced Cardiac Hypertrophy in Mice , 2002, Circulation.

[28]  F. Kelly,et al.  Impaired Endothelial Regulation of Ventricular Relaxation in Cardiac Hypertrophy: Role of Reactive Oxygen Species and NADPH Oxidase , 2001, Circulation.

[29]  K. Node,et al.  Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy. , 2001, The Journal of clinical investigation.

[30]  A. Sachinidis,et al.  Angiotensin II-induced Stimulation of p21-activated Kinase and c-Jun NH2-terminal Kinase Is Mediated by Rac1 and Nck* , 2001, The Journal of Biological Chemistry.

[31]  A. Lin,et al.  Activation of NF-κB is required for hypertrophic growth of primary rat neonatal ventricular cardiomyocytes , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[32]  D. Sorescu,et al.  Novel gp91phox Homologues in Vascular Smooth Muscle Cells: nox1 Mediates Angiotensin II-Induced Superoxide Formation and Redox-Sensitive Signaling Pathways , 2001, Circulation research.

[33]  D. Harrison,et al.  Electron spin resonance characterization of the NAD(P)H oxidase in vascular smooth muscle cells. , 2001, Free radical biology & medicine.

[34]  E. Sahai,et al.  Regulation of Mitogen-Activated Protein Kinases in Cardiac Myocytes through the Small G Protein Rac1 , 2001, Molecular and Cellular Biology.

[35]  P. Simpson,et al.  Autonomous and growth factor-induced hypertrophy in cultured neonatal mouse cardiac myocytes. Comparison with rat. , 2000, Circulation research.

[36]  S. Sanlioglu,et al.  Endocytosis and Nuclear Trafficking of Adeno-Associated Virus Type 2 Are Controlled by Rac1 and Phosphatidylinositol-3 Kinase Activation , 2000, Journal of Virology.

[37]  J. Settleman,et al.  Rho family GTPases: more than simple switches. , 2000, Trends in cell biology.

[38]  Hiroyuki Tsutsui,et al.  Treatment With Dimethylthiourea Prevents Left Ventricular Remodeling and Failure After Experimental Myocardial Infarction in Mice: Role of Oxidative Stress , 2000, Circulation research.

[39]  Haibin Xia,et al.  A simple method for the rapid generation of recombinant adenovirus vectors , 2000, Gene Therapy.

[40]  N. Dhalla,et al.  Role of oxidative stress in cardiovascular diseases , 2000, Journal of hypertension.

[41]  G. Condorelli,et al.  The Akt-Glycogen Synthase Kinase 3β Pathway Regulates Transcription of Atrial Natriuretic Factor Induced by β-Adrenergic Receptor Stimulation in Cardiac Myocytes* , 2000, The Journal of Biological Chemistry.

[42]  T. Hewett,et al.  Altered focal adhesion regulation correlates with cardiomyopathy in mice expressing constitutively active rac1. , 2000, The Journal of clinical investigation.

[43]  A. Takeshita,et al.  Direct evidence for increased hydroxyl radicals originating from superoxide in the failing myocardium. , 2000, Circulation research.

[44]  D. Kass,et al.  Intravenous allopurinol decreases myocardial oxygen consumption and increases mechanical efficiency in dogs with pacing-induced heart failure. , 1999, Circulation research.

[45]  Y. Suh,et al.  Cell transformation by the superoxide-generating oxidase Mox1 , 1999, Nature.

[46]  R. Alexander,et al.  Reactive Oxygen Species Mediate the Activation of Akt/Protein Kinase B by Angiotensin II in Vascular Smooth Muscle Cells* , 1999, The Journal of Biological Chemistry.

[47]  D. Sawyer,et al.  Inhibition of copper-zinc superoxide dismutase induces cell growth, hypertrophic phenotype, and apoptosis in neonatal rat cardiac myocytes in vitro. , 1999, Circulation research.

[48]  Y. Fujio,et al.  Akt Mediates Cytoprotection of Endothelial Cells by Vascular Endothelial Growth Factor in an Anchorage-dependent Manner* , 1999, The Journal of Biological Chemistry.

[49]  B. Babior.  NADPH oxidase: an update. , 1999, Blood.

[50]  A. Clerk,et al.  Cellular mechanisms of cardiac hypertrophy , 1998, Journal of Molecular Medicine.

[51]  W R Taylor,et al.  Role of NADH/NADPH oxidase-derived H2O2 in angiotensin II-induced vascular hypertrophy. , 1998, Hypertension.

[52]  K. Tanaka,et al.  A requirement for the rac1 GTPase in the signal transduction pathway leading to cardiac myocyte hypertrophy. , 1998, The Journal of clinical investigation.

[53]  K. Mihara,et al.  Inhibitory effects of antioxidants on neonatal rat cardiac myocyte hypertrophy induced by tumor necrosis factor-alpha and angiotensin II. , 1998, Circulation.

[54]  L. Oberley,et al.  Redox gene therapy for ischemia/reperfusion injury of the liver reduces AP1 and NF-κB activation , 1998, Nature Medicine.

[55]  R. A. Hunt,et al.  Molecular mechanisms of angiotensin II in modulating cardiac function: intracardiac effects and signal transduction pathways. , 1997, Journal of molecular and cellular cardiology.

[56]  C. Long,et al.  A growth factor for cardiac myocytes is produced by cardiac nonmyocytes. , 1991, Cell regulation.

[57]  G. Schultz,et al.  Morphological, biochemical, and electrophysiological characterization of a clonal cell (H9c2) line from rat heart. , 1991, Circulation research.

[58]  E. Myers,et al.  Basic local alignment search tool. , 1990, Journal of molecular biology.

[59]  Eugene W. Myers,et al.  Basic local alignment search tool. Journal of Molecular Biology , 1990 .

[60]  P. Simpson,et al.  Stimulation of hypertrophy of cultured neonatal rat heart cells through an alpha 1-adrenergic receptor and induction of beating through an alpha 1- and beta 1-adrenergic receptor interaction. Evidence for independent regulation of growth and beating. , 1985, Circulation research.

[61]  P. Simpson,et al.  Differentiation of Rat Myocytes in Single Cell Cultures with and without Proliferating Nonmyocardial Cells: Cross‐Striations, infrastructure, and Chronotropic Response to Isoproterenol , 1982, Circulation research.

[62]  C. Iadecola,et al.  NF-kappaB regulates phagocytic NADPH oxidase by inducing the expression of gp91phox. , 2006, The Journal of biological chemistry.

[63]  宮本 卓也.  Activation of distinct signal transduction pathways in hypertrophied hearts by pressure and volume overload , 2003 .

[64]  C. Croce,et al.  TNF-alpha signal transduction in rat neonatal cardiac myocytes: definition of pathways generating from the TNF-alpha receptor. , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[65]  H. Itoh,et al.  Interaction of myocytes and nonmyocytes is necessary for mechanical stretch to induce ANP/BNP production in cardiocyte culture. , 1998, Journal of cardiovascular pharmacology.